Sanofi : Join the dance
>Clinical launch of its COVID-19 vaccine - Sanofi and GSK announced at the end of last week that their COVID-19 candidate vaccine has entered the clinical trial phase. This phase I/II will recruit 440 participants at 11 sites in the US and will have as its main objective to evaluate the safety of its candidate vaccine. This first step was expected but facilitates confirmation of the timings previously indicated by the companies. The aim now is to obtain its first cli...Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.